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Abstract
Objective—This study aimed to evaluate the incidence of cervical cancer by nativity [United 
States (US) versus non-US], neighborhood socioeconomic status and ethnic enclave among 
Hispanics and Asians in California.
Methods—Using data from the California Cancer Registry, information on all primary invasive 
cervical cancer (Cca) patients diagnosed in California from January 1, 1990 through December 31, 
2004 was obtained. We analyzed the influence of enclave, socioeconomic status and nativity on 
Cca incidence.
Results—Among the 22,189 Cca cases diagnosed between 1990 and 2004, 50% were non-
Hispanic white, 39% Hispanic and 11% Asian women, and 63% US-born. Seventy percent of the 
Cca cases were squamous cell carcinoma, 19% adenocarcinoma and 11% other histologies. Higher 
incidence of Cca was observed in high enclave (76%) and low socioeconomic status (70%) 
neighborhoods. By ethnic group, US-born women showed lower rates of squamous cell carcinoma 
compared to foreign-born women. Hispanics living in low socioeconomic and high enclave had 
12.7 times higher rate of Cca than those living in high socioeconomic, low enclave neighborhoods. 
For Asian women incidence rates were 6 times higher in the low socioeconomic, high enclave 
neighborhoods compared to those living in high socioeconomic, low enclave neighborhoods.
Conclusion—More targeted outreach to increase Pap smear screening and human papilloma 
virus vaccination for women living in high enclave neighborhoods can help decrease the incidence 
of Cca in these groups of women.
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Invasive cervical cancer (Cca) used to be the principal cause of cancer death for women in 
the United States. Since the introduction of the Pap smear, the incidence of Cca has declined 
considerably [1]. However, 12,360 new Cca cases and 4020 deaths related to this disease are 
still expected in 2014 [2]. Moreover, significant disparities exist based on ethnicity and 
socioeconomic status (SES) [3–9]. For example, according to the Center for Disease Control 
and Prevention, Hispanic women show a higher rate of Cca than US women from all other 
ethnicities [8]. Discrepancies also exist between different Asian subgroups with more Cca 
cases in Vietnamese women compared to other Asians ethnicities [10,11]. Additionally, 
foreign-born (FB) women and women living in higher poverty counties seem to have a 
greater incidence of Cca [3], and SEER data also demonstrate a 30% higher incidence and 
71% higher mortality rate from Cca for women living in counties with high poverty as 
compared to wealthier counties [4].
California, with its large and diverse population, provides a unique opportunity for studying 
the influence of both ethnicity and SES on Cca. Hispanic and Asian populations represent 
two of the largest and fastest growing immigrant and minority populations in the United 
States and California. In 2011, the California population was 14% Asian and 38% Hispanic 
[12]. These two ethnic groups include women from many different countries of origin and 
cultures, as well as immigration histories, all of which can influence their lifestyle and risk 
factors, as well as their SES and access to health care. Additionally, these populations 
continue to immigrate, allowing for an analysis on the impact of place of birth (nativity). 
Finally, subpopulations of these minorities show different degrees of integration facilitating 
the study of the influence of neighborhood, including the SES and enclave features. Here, 
we refer to ethnic enclaves as neighborhoods that maintain more cultural mores and are 
ethnically distinct from the surrounding area.
This study aimed to evaluate the impact of nativity, SES and ethnic enclave on the incidence 
of Cca in California to identify particularly high risk populations to target with Cca 
screening and vaccination programs.
Methods
Cancer cases from the California Cancer Registry (CCR), comprising four of the National 
Cancer Institute’s Surveillance Epidemiology and End Results (SEER) program registries 
[13] were reviewed. Information on all California residents diagnosed with primary Cca 
(International Classification of Diseases for Oncology, 3rd Edition [ICD-O-3] site code 
153.9) from January 1, 1990 through December 31, 2004 was obtained. Data were restricted 
to this time period due to available population estimate data defined by nativity and the 
neighborhood factors of interest.
Primary Cca cases were classified according to histologic type as squamous cell carcinoma 
(histology codes 8050–8130), adenocarcinoma (histology codes 8140–8490), and others 
(histology codes 8000–8046 and 8500–9582). Tumors were classified by stage (SEER 
summary stage) as localized, regional (regional extension, regional nodes, regional extension 
and nodes, and regional NOS), distant, and unknown (blank and unspecified).
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Classification of Asian race was improved by application of the North American Association 
of Central Cancer Registries Pacific Islander Identification Algorithm [14], and Hispanic 
ethnicity was improved by application of the North American Association of Central Cancer 
Registries Hispanic Identification Algorithm [15].
Because patients in the cancer registry with unknown birthplace data are more likely to be 
US-born than those with available data [16–19], a method on the basis of patients’ social 
security numbers (SSN) to classify patient immigrant status, as described previously [20], 
was developed. Among Asian subgroups, registry data on nativity were available for 79.4% 
(76.4% from hospital medical records and 3.1% from death certificates) of eligible cases. 
For the 20.6% of cases with unknown birthplace, statistical imputation using the patient’s 
SSN was used to determine immigrant status, as SSN sequences are associated with its year 
of issue. By comparing the age of SSN issue with self-reported birthplace in previously 
interviewed cancer patients (n = 1836) and based on maximization of the area under the 
receiver operating characteristic curve and confirmation with logistic regression modeling, 
patients receiving a SSN before age 25 years were considered US-born, and those who had 
received an SSN at or after age 25 years as foreign-born. This age cut point resulted in 84% 
sensitivity and 80% specificity for assigning foreign-born status across the Asian 
populations. The 1.8% of cases with missing or invalid SSNs was assigned an immigrant 
status on the basis of the ethnicity–sex–age birthplace distribution of the overall sample. 
Incidence rates for US-born Korean, South Asian and Vietnamese patients were not 
computed due to small case (N = 27 for all 3 groups) and population numbers.
Among Hispanics, registry data on nativity were available for 77.6% (74.3% from hospital 
medical records and 3.4% from death certificates) of eligible cases. We estimated nativity 
for the minority of patients with unknown birthplace as above. For Hispanics, those who 
received their SSN before age 20 years were considered US-born and those who received 
their SSN at or after age 20 years were considered foreign-born. The cut point of 20 years 
was determined by comparisons with self-reported nativity from interviews with 1127 
Hispanic cancer patients [16,17] as noted above. The age cut point of 20 years resulted in 
81% sensitivity and 80% specificity for detecting foreign-born status in Hispanics. The 5.0% 
of Hispanic cases with missing or invalid SSNs were assigned a nativity status based on the 
known distribution of nativity within matched strata of race/ethnicity, sex, and age in the 
overall California Cancer Registry patient population. Analyses for detailed Hispanic 
subgroups (e.g., Mexican and Puerto Rican) could not be conducted given the substantial 
proportion (>40%) of cases classified as “Hispanic, not otherwise specified” on Hispanic 
origin. Approximately 84% of California Hispanics are of Mexican origin [21,22], followed 
by 9% of Central American origin [22]. By using patient residential address and small-area 
(census tract) information from the 2000 US Census, we classified neighborhood SES for all 
patients and ethnic enclave status for every Hispanic and Asian patient. Analyses using these 
variables were limited to the pericensal period between January 1st, 1998 and December 
31st, 2002, and included 7373 cases of Cca among NH Whites, Hispanics, and Asian 
subgroups. A neighborhood-level measure of SES based on a previously described index 
that incorporates 2000 US Census data on education, occupation, unemployment, household 
income, poverty, rent, and house values was assigned [23]. Ninety five percent (95.2%) of 
patients’ address at diagnosis was geocoded to a census tract. The remaining cases without a 
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street address or whose address could not be precisely geocoded (4.8%) were randomly 
assigned to a census tract within their ZIP code of residence. Based on residential census 
tracts, each patient was assigned to a quintile of neighborhood SES according to the 
statewide distribution of the SES index across all census tracts in California [24]. For the 
analysis, quintiles 1 to 2 (lower SES) and quintiles 3 to 5 (higher SES) were combined.
Patients were classified according to neighborhood Hispanic (for Hispanic race/ethnicity) 
and Asian (for Asian/Pacific Islander race/ethnicity) enclave status based on the concept of 
an ethnic enclave as a geographic unit with higher concentration of foreign-born race/
ethnicity-specific residents and language(s) than other geographic units in California. As 
described previously [24–26], residence in an enclave was characterized by applying 
principal components analysis [27] to 2000 US Census block group level data on selected 
census variables, which was, in turn averaged to the census tract level. For Hispanics, data 
on linguistic isolation, English fluency, Spanish language use, Hispanic ethnicity, 
immigration history, and nativity were included. For Asians, data on linguistic isolation, 
English fluency, Asian language use, Asian race, and immigration history were included. 
Each case was assigned to a quintile of neighborhood ethnic enclave status based on the 
distribution of the enclave index across all census tracts in California [23]. Quintiles 1 to 3 
(lower enclave status) and quintiles 4 to 5 (higher enclave status) were combined for the 
analysis.
From the 1990 and 2000 US Census Summary File 3 (SF-3), population counts to estimate 
incidence rates by sex, race/ethnicity, immigrant status, and 5-year age group for California 
were obtained. For intercensal years, the foreign-born Hispanic and Asian population sizes 
were estimated by using cohort component interpolation and extrapolation methods [28], 
adjusting estimates to the populations by age and year provided by the US Census for years 
1990 to 2004, based on data availability. Data from the 5% integrated public use microdata 
sample of the census to estimate age- and birthplace-specific population counts for the Asian 
ethnic groups [26,29] were also used by smoothing with a spline-based function [30]. For 
the analyses of neighborhood SES and ethnic enclave status, 2000 US Census population 
estimates by race/ethnicity and sex at the census tract level were used. Because census data 
on nativity are not available at the census tract level, the database containing nativity data 
was separate from the one containing neighborhood SES and ethnic enclave status, and these 
variables could not be cross-classified.
Statistical analyses
SEER Stat software 8.0 [15] was used to compute age-adjusted incidence rates (directly 
standardized to the 2000 US standard million population) with 95% CIs. To comply with 
CCR regulations, case counts or rates based on fewer than 5 cases were not present. Age-
adjusted incidence rates according to race/ethnicity and nativity are stratified by tumor 
pathology, summary stage and age group at diagnosis (15–39 years of age, 40–59 years of 
age, and 60+ years of age) for the period 1990–2004. Time trends between 1990 and 2004 
were examined using Joinpoint Regression software [31] to calculate the annual percentage 
changes (APCs) in log-linear regression models that allowed up to two Joinpoints. Age-
adjusted incidence rates were also computed according to race/ethnicity stratified by 
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neighborhood SES and/or enclave status for individual tumor pathologies for the period 
1998–2002.
Results
Between 1990 and 2004, 22,189 Cca cases were diagnosed among non-Hispanic White, 
Hispanic, and Asian American women living in California and were included in this analysis 
(Table 1). Histology distribution included 70% with SCC, 19% with adenocarcinoma and 
11% other histologies. Forty-four percent (44%) of women were between age 40 and 59, 
30% were between 15 and 39, and 26% were older than 59 years old. Approximately, half of 
patients had localized disease (51%), 32% regional disease, 10% distant disease and 7% 
unknown. In this population, 11,125 were NHW women, 8670 Hispanic and 2394 Asian 
women. Among Asians, 6 different ethnic populations are included that comprised 
approximately 85% of all non-Hispanic Asian and Pacific Islander patients with Cca in the 
CCR in the study period. Five hundred fifteen (515) (21.7%) cases were Chinese, 213 
(8.9%) Japanese, 773 (32.3%) Filipino, 310 (12.9%) Korean, 93 (3.9%) South Asian 
(including Asian Indians, Pakistanis, Sri Lankans, and Bangladeshis), and 490 (20.5%) 
Vietnamese. The vast majority of Hispanic and Asian women diagnosed with Cca during 
this time period were FB, 70% and 91% respectively. Principal demographic and tumor 
characteristic difference between groups (Table 1) included a larger proportion of FB women 
older than 60 years old compared to US-born groups, reflecting their distributions in the 
general population. Moreover, a higher percentage of South Asian women had distant 
disease (12%) and a larger proportion of US-born Chinese had localized disease (65%).
From 1990 to 2004, the incidence of Cca declined significantly for all groups of women 
except for US-born Asian women, among whom rates were already low (Fig. 1). There was 
a reduction of SCC incidence for all groups of women (Fig. 1). Among Asian ethnic 
subgroups, FB-Vietnamese had the greatest annual percentage of change (APC) between 
1992 and 2002 for SCC (−14.19) compared to all other ethnic groups. The incidence of 
adenocarcinoma did not show a significant decrease with the exception of FB-Asian women, 
who had a significant decrease in adenocarcinoma incidence (Fig. 1). Local and regional 
diseases declined significantly over the 14-year period for NHW, FB-and US-born Hispanics 
and FB-Asian [APC: −2.58, −4.39, −12.42 (2000–2004), −5.62 for local disease and −2.06, 
−3.96, −2.27 and −6.73 for regional disease respectively]. The incidence of distant disease 
has only decreased significantly in FB-Hispanics and Asian (APC: −5.71 and −4.40, 
respectively).
NHW vs other ethnicity
Compared to NHW, there was a higher incidence of Cca in FB-Vietnamese, Hispanics, 
Korean, Filipino and Japanese women and in US-born Hispanics (Fig. 2). However, Chinese, 
FB-South Asian, and US-born Japanese and Filipino women had lower or comparable 
incidence of Cca than NHW.
Concerning histology, US-born Chinese and Japanese had a lower rate of SCC, and FB-
Korean had a higher rate of SCC compared to NHW. Those three groups of women had a 
similar rate of adenocarcinoma compared to NHW. For FB-South Asian and Chinese, the 
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difference with NHW was only for adenocarcinoma. Regarding incidence rates by age, all 
FB groups and US-born Hispanic had higher rates compared to NHW among women older 
than 60 years old (Fig. 2). Concerning stage, FB-Hispanics and US-born Filipino had higher 
IRRs for distant disease compared to NHW. Compared to all other ethnic groups, highest 
rates of Cca per 100,000 were seen among FB-Vietnamese, and FB-Koreans, US-born 
Japanese and Filipino had higher percentages of adenocarcinoma (31% and 26%, 
respectively).
Nativity (FB vs US-born)
Within each ethnic group, FB women showed higher rates of SCC compared to US-born 
women (Fig. 2). FB-Hispanic and FB-Japanese women had also more adenocarcinoma 
compared to their US-born counterparts. However, FB-Chinese had less adenocarcinoma 
compared to US-born Chinese. Concerning age at diagnosis, more FB women were older 
than 60 years old compared to US-born. The stage distribution was similar comparing US 
with foreign-born, except for Filipino women for whom there were proportionally more 
regional disease for FB women compared to US-born women.
Socioeconomic status (SES)
Seventy percent (70%) of Cca were diagnosed among residents of low SES neighborhoods 
(lowest two quintiles statewide). For NHW, Hispanic and FB-Japanese, FB-Filipina, FB-
South Asian and FB-Vietnamese women, most of the Cca cases lived in low SES 
neighborhoods (58%, 87%, 51%, 63%, 57%, and 72%, respectively). In contrast, for all 
Chinese, US-born Japanese, and US-born Filipina cases, there was more Cca in the high 
SES neighborhood quintiles (60%, 72%, 56%, respectively). Regarding histology, higher 
rates of SCC were seen in low SES neighborhoods for NHW and Hispanics [rate (95% CI); 
1.6 (1.5–1.7) vs 1.3 (1.2–1.4) and 2.2 (2.1–2.3) vs 0.4 (0.4–0.5), for low SES and high SES 
quintile neighborhoods, for NHW and Hispanics, respectively]. For NHW, higher rates of 
adenocarcinoma were seen in high SES neighborhoods [rate (95% CI); 0.5 (0.4–0.5) and 0.6 
(0.6–0.7), for low and high SES neighborhoods, respectively]. However, a higher rate of 
adenocarcinoma was diagnosed in low SES neighborhoods for Hispanics [rate (95% CI); 0.5 
(0.5–0.6) and 0.1 (0.1–0.2), for low and high quintiles SES neighborhood, respectively]. No 
difference was seen regarding histology and neighborhood SES for Asian subgroups. Stage 
and age distribution data by SES neighborhood quintiles were not available.
Enclave
Seventy-six percent (76%) of Asian and Hispanic Cca cases were observed in high enclave 
neighborhoods. The proportion of Cca cases in high quintile ethnic enclave neighborhoods 
are as follows: Vietnamese 88%, Korean 85%, Chinese 84%, Filipino 75%, Hispanic 75%, 
and Japanese 52%. In contrast, South Asians had more Cca in less ethnically isolated 
neighborhoods (51%). Regarding histology, a higher incidence of SCC was noted in high 
ethnic enclaves for Hispanics and all Asian subgroups [rate (95% CI); 0.5 (0.5–0.6) vs 3 
(2.8–3.1) and 0.2 (0.1–0.2) vs 0.8 (0.7–0.9), for low and high ethnic enclaves, for Hispanics 
and Asians, respectively]. Similarly, higher rates of adenocarcinoma were also observed 
[rate (95% CI); 0.2 (0.1–0.2) vs 0.6 (0.6–0.7) and 0.1 (0–0.1) vs 0.2 (0.2–0.3), for low and 
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high ethnic enclaves, for Hispanics and Asians, respectively]. Data about age and stage 
distribution by enclave neighborhoods were not available.
Enclave and socioeconomic status
Excluding cases in NHW women, 67% of Cca were diagnosed in low SES, high enclave 
neighborhoods. Hispanics living in low SES and high enclave neighborhoods had 12.7 times 
(95% CI; 11.2–14.3) higher rate of Cca than those living in high SES, low enclave 
neighborhoods (Table 2). For Asian women, incidence rates were 6 times (95% CI; 4.9–7.5) 
higher in the low SES, high enclave neighborhoods compared to Asians living in high SES, 
low enclave neighborhoods. Hispanic and Asian women living in low SES, low enclave 
neighborhoods also had more Cca than those living in high SES, low enclave neighborhoods 
[IRR (95% CI); 1.6 (1.4–1.8), 1.2 (0.9–1.6), respectively]. Regarding histologies, Hispanics 
living in low SES, high enclave neighborhoods had 13.9 (95% CI; 12.0–16.1) times more 
SCC and 9.0 times more adenocarcinoma (95% CI; 6.9–11.7) than those living in high SES, 
low enclave neighborhoods. Asian women living in low SES, high enclave neighborhood 
had 6.7 (95% CI; 5.1–8.8) times more SCC and 4.4 (2.9–6.7) times more adenocarcinoma 
compared to those living in high SES, low enclave neighborhoods.
Discussion
This study demonstrates the significant impact of nativity, SES and enclave on Cca 
incidence for Asian and Hispanic women, who have among the highest incidence of Cca of 
all racial/ethnic groups in the US. Living in lower SES and ethnically concentrated 
neighborhoods, as well as being foreign-born, was associated with considerably higher 
incidence. Specifically, IRRs for SCC comparing US-born and FB women of the same 
ethnic group were higher for all FB women. Higher incidence rate were noted in low SES 
neighborhoods and in high enclave neighborhoods. Hispanics living in low SES and high 
enclave had 12.7 times (95% CI; 11.2–14.3) higher rate of Cca than those living in high 
SES, low enclave neighborhoods. For Asian women incidence rates were 6 times (95% CI; 
4.9–7.5) higher in low SES, high enclave neighborhoods compared to those living in high 
SES, low enclave neighborhoods. These findings highlight the need for improved screening 
approaches for these high risk populations and also identify key populations to target for 
HPV vaccination.
In California from 1990 to 2004, there was a reduction of the SCC incidence over time for 
non-Hispanic Whites, Hispanics, and Asians. However, for most groups, the incidence of 
adenocarcinoma did not decrease significantly over time. This result is consistent with other 
studies which have shown the rate of adenocarcinoma increasing or remaining stable [1,3]. 
Pap smear seems to be quite effective to detect pre-invasive lesion for SCC but less helpful 
for pre-invasive adenocarcinoma lesion, perhaps explaining the stable rates of 
adenocarcinoma [32,33].
The three groups in our study with the highest rates of Cca were FB-Vietnamese, FB-
Hispanic, and FB-Korean women. This result about the incidence of Cca among ethnic 
subgroups is similar with another study [10]. Indeed, in that study, the incidence rate per 
100,000 woman-years for invasive cervical carcinoma was 18.9, 16.6 and 11.9 for 
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Vietnamese, Hispanic and Korean women respectively. Moreover, in support of the prior 
research [34] and consistent with a recent report on national cancer incidence trends [11], 
our study showed that FB-Vietnamese women had the highest incidence of Cca and highest 
rate of decline of SCC incidence between 1992 and 2002. However, those studies didn’t 
assess the incidence patterns by nativity and neighborhood characteristics for Hispanics and 
Asian subgroups.
By ethnic group, FB women showed higher rates of SCC compared to US-born women. 
Another report also shows a similar influence of FB status on Cca incidence among 
Hispanics with less impact in other ethnic groups like Asian/Pacific Islander and African 
American [3]. These incidence patterns are likely largely reflective of screening patterns. 
Several studies have demonstrated that FB-Asian and Hispanic women are considerably less 
likely to be screened for cervical cancer [35–37]. Recent immigrants were 3 times more 
likely to never have undergone a Pap smear compared to US-born women [37]. Lack of 
knowledge of the US health care system, screening programs, and language barriers were all 
reported to limit the access to screening for FB women [36]. Additionally, 34% of the 
immigrant population is uninsured compared to 12% of the US-born population [38], which 
likely also contributes to a low screening rate in FB women.
Higher Cca incidence rates were noted in low SES neighborhoods. Other reports also show a 
similar association of low SES and high Cca incidence [3,4]. A SEER review demonstrates 
that women living in high poverty counties have a higher incidence rate than women living 
in low poverty counties [4]. The lack of access to health insurance and health care in these 
low SES groups likely contributes to low rates of screening and eventually an increase in 
Cca incidence [37].
Higher Cca incidence was found in high enclave or ethnically distinct neighborhoods. As 
noted previously, foreign-birth and recent immigration, lack of acculturation and language 
barriers, which are associated with residence in these enclaves, contribute to lack of 
screening which can increase the rate of Cca [36–38]. Enclave was also associated with an 
increase of Cca cases in the Haitian community in Florida [39]. To our knowledge, this study 
is the first to determine the impact of the enclave on Cca incidence for the Asian and 
Hispanic community in California. Neighborhood SES and ethnic enclave are highly 
correlated and, considered together, women in neighborhoods of high enclave and low SES 
had considerably higher incidence rates of Cca, suggesting a synergistic effect. It is 
concerning to see that this population of FB women have lower rates of HPV vaccine since 
its introduction in 2006 [40] and likely places them at higher risk of Cca, as demonstrated by 
the current study. Findings of our study highlight the fact that more efforts should be 
targeted towards HPV vaccination in these populations.
There are some limitations of this study. Data regarding the HPV status and other Cca risk 
factors were not available. Information about length of residency in the US, screening 
behavior and health insurance access were also not available. Furthermore, in some ethnic 
subgroups, populations were too small to generate stable estimates. We also used, as in other 
studies, an area-based measure on SES because individual SES was not available in the 
California Cancer Registry. The database containing nativity data was separate from the one 
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containing neighborhood SES and ethnic enclave status, and these variables could not be 
cross-classified. Finally, for 20.6% of Asians and 22.4% of Hispanics, data regarding 
nativity were missing. A method on the basis of the patients’ social security numbers (SSN) 
was used with some limitation. Also, the current study included women from California only 
and might not be representative of populations living in different areas.
Conclusion
The incidence of invasive cervical cancer declined in NHW, Hispanics and Asian women in 
California from 1990 through 2004, and disparities in incidence have narrowed considerably 
over time. However, despite significant declines, rates remain high among foreign-born 
Hispanics and Asians, especially for adenocarcinoma. The fact that women living in low 
SES and high enclave neighborhoods have considerably higher incidence is worthy of 
further exploration and can be used to inform targeted cervical cancer screening and 
prevention efforts.
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HIGHLIGHTS
• Cervical cancer cases from four of the SEER program registries were 
reviewed.
• Influence of enclave and nativity on cervical cancer incidence is reported.
• More efforts should be done to increase Pap smear screening in those groups.
Froment et al. Page 12
Gynecol Oncol. Author manuscript; available in PMC 2017 December 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 1. 
Invasive cervical cancer trends for California non-Hispanic White, Hispanic and Asian 
subgroups by nativity, 1990–2004. *Total: incidence rate for cervical cancer. APC for NHW: 
−2.44+ (1990–2004); −6.37+ (1990–1994), 2.00 (1994–1997), −5.03+ (1997–2004); −0.60 
(1990–2004), for total invasive cervical cases, SCC and adenocarcinoma, respectively. APC 
for US born Hispanic: −1.40+ (1990–2002), −15.06 (2002–2004); −5.15+ (1990–1995), 1.45 
(1995–2000), −9.84+ (2000–2004); 0.22 (1990–2004), for total invasive cervical cases, SCC 
and adenocarcinoma, respectively. APC for FB Hispanic: −4.64+ (1990–2004); 
−5.07+ (1990–2004); −1.76 (1990–2004), for total invasive cervical cases, SCC and 
adenocarcinoma, respectively. APC for US-born Asiatic: 1.15 (1990–2004); −3.62+ (1990–
2004); N/A, for total invasive cervical cases, SCC and adenocarcinoma, respectively. APC 
for FB Asiatic: 3.74 (1990–1993), −7.32+ (1994–2004); 5.62 (1990–1992), −8.07+ (1993–
2004); −3.95+ (1990–2004), for total invasive cervical cases, SCC and adenocarcinoma, 
respectively. +: indicates a significant APC. N/A: cannot calculate due to low frequency of 
cases.
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Fig. 2. 
Invasive cervical cancer incidence rates per 100,000, for all subgroups of women in 
California, 1990–2004. A. Total invasive cervical cancer rates per 100,000 for all subgroups 
of women. B. Adenocarcinoma and squamous cell carcinoma incidence rate per 100,000, 
comparing US-born with foreign-born women of the same ethnicity. (For all the data please 
see Supplement 1.) μ: non-Hispanic white, £: foreign-born, *: South Asian, §: Vietnamese, 3: 
adenocarcinoma, **: squamous cell carcinoma.
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